

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in radiation therapy of... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-1931/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-1931" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in radiation therapy of pancreatic cancer" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in radiation therapy of pancreatic cancer.">
            <meta name="og:description" content="Read the latest article version by Bhanu Prasad Venkatesulu, Cheng-En Hsieh, Keith L Sanders, Sunil Krishnan, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="17772">
            <meta name="article-id" content="16272">
            <meta name="dc.title" content="Recent advances in radiation therapy of pancreatic cancer">
            <meta name="dc.description" content="Pancreatic cancer has a dismal prognosis with an overall survival outcome of just 5% at five years. However, paralleling our improved understanding of the biology of pancreatic cancer, treatment paradigms have also continued to evolve with newer advances in surgical techniques, chemotherapeutic agents, radiation therapy (RT) techniques, and immunotherapy paradigms. RT dose, modality, fraction size, and sequencing are being evaluated actively, and the interplay between RT and immune effects has opened up newer avenues of research. In this review, we will emphasize recent advances in RT for pancreatic cancer, focusing on preoperative chemoradiation, RT dose escalation, sparing of the spleen to reduce lymphopenia, and combination of RT with immunotherapy.">
            <meta name="dc.subject" content="Dose escalation, immunotherapy, neoadjuvant therapy, spleen sparing, radiotherapy ">
            <meta name="dc.creator" content="Venkatesulu, Bhanu Prasad">
            <meta name="dc.creator" content="Hsieh, Cheng-En">
            <meta name="dc.creator" content="Sanders, Keith L">
            <meta name="dc.creator" content="Krishnan, Sunil">
            <meta name="dc.date" content="2018/12/13">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.16272.1">
            <meta name="dc.source" content="F1000Research 2018 7:1931">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Dose escalation">
            <meta name="prism.keyword" content="immunotherapy">
            <meta name="prism.keyword" content="neoadjuvant therapy">
            <meta name="prism.keyword" content="spleen sparing">
            <meta name="prism.keyword" content="radiotherapy ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/12/13">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="1931">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.16272.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-1931">
            <meta name="citation_title" content="Recent advances in radiation therapy of pancreatic cancer">
            <meta name="citation_abstract" content="Pancreatic cancer has a dismal prognosis with an overall survival outcome of just 5% at five years. However, paralleling our improved understanding of the biology of pancreatic cancer, treatment paradigms have also continued to evolve with newer advances in surgical techniques, chemotherapeutic agents, radiation therapy (RT) techniques, and immunotherapy paradigms. RT dose, modality, fraction size, and sequencing are being evaluated actively, and the interplay between RT and immune effects has opened up newer avenues of research. In this review, we will emphasize recent advances in RT for pancreatic cancer, focusing on preoperative chemoradiation, RT dose escalation, sparing of the spleen to reduce lymphopenia, and combination of RT with immunotherapy.">
            <meta name="citation_description" content="Pancreatic cancer has a dismal prognosis with an overall survival outcome of just 5% at five years. However, paralleling our improved understanding of the biology of pancreatic cancer, treatment paradigms have also continued to evolve with newer advances in surgical techniques, chemotherapeutic agents, radiation therapy (RT) techniques, and immunotherapy paradigms. RT dose, modality, fraction size, and sequencing are being evaluated actively, and the interplay between RT and immune effects has opened up newer avenues of research. In this review, we will emphasize recent advances in RT for pancreatic cancer, focusing on preoperative chemoradiation, RT dose escalation, sparing of the spleen to reduce lymphopenia, and combination of RT with immunotherapy.">
            <meta name="citation_keywords" content="Dose escalation, immunotherapy, neoadjuvant therapy, spleen sparing, radiotherapy ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Bhanu Prasad Venkatesulu">
            <meta name="citation_author_institution" content="Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA">
            <meta name="citation_author" content="Cheng-En Hsieh">
            <meta name="citation_author_institution" content="Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA">
            <meta name="citation_author_institution" content="Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA">
            <meta name="citation_author_institution" content="The University of Texas MD Anderson Cancer Center-UT Health Graduate School of Biomedical Sciences, Houston, TX, USA">
            <meta name="citation_author_institution" content="Department of Radiation Oncology, Chang Gung Memorial Hospital, Linkou and Chang Gung University, Taoyuan, Taiwan">
            <meta name="citation_author" content="Keith L Sanders">
            <meta name="citation_author_institution" content="Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA">
            <meta name="citation_author" content="Sunil Krishnan">
            <meta name="citation_author_institution" content="Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA">
            <meta name="citation_author_institution" content="Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA">
            <meta name="citation_author_institution" content="The University of Texas MD Anderson Cancer Center-UT Health Graduate School of Biomedical Sciences, Houston, TX, USA">
            <meta name="citation_publication_date" content="2018/12/13">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="1931">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.16272.1">
            <meta name="citation_firstpage" content="1931">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-1931/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-1931.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=17772 /> <input type=hidden id=articleId name=articleId value=16272 /> <input type=hidden id=xmlUrl value="/articles/7-1931/v1/xml"/> <input type=hidden id=xmlFileName value="-7-1931-v1.xml"> <input type=hidden id=article_uuid value=c14c0f99-905c-4b3b-93f4-9432f9f5896f /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in radiation therapy of pancreatic cancer"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.16272.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.16272.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-1931"
  },
  "headline": "Recent advances in radiation therapy of pancreatic cancer",
  "datePublished": "2018-12-13T17:49:44",
  "dateModified": "2018-12-13T17:49:44",
  "author": [
    {
      "@type": "Person",
      "name": "Bhanu Prasad Venkatesulu"
    },    {
      "@type": "Person",
      "name": "Cheng-En Hsieh"
    },    {
      "@type": "Person",
      "name": "Keith L Sanders"
    },    {
      "@type": "Person",
      "name": "Sunil Krishnan"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Pancreatic cancer has a dismal prognosis with an overall survival outcome of just 5% at five years. However, paralleling our improved understanding of the biology of pancreatic cancer, treatment paradigms have also continued to evolve with newer advances in surgical techniques, chemotherapeutic agents, radiation therapy (RT) techniques, and immunotherapy paradigms. RT dose, modality, fraction size, and sequencing are being evaluated actively, and the interplay between RT and immune effects has opened up newer avenues of research. In this review, we will emphasize recent advances in RT for pancreatic cancer, focusing on preoperative chemoradiation, RT dose escalation, sparing of the spleen to reduce lymphopenia, and combination of RT with immunotherapy."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-1931",
            "name": "Recent advances in radiation therapy of pancreatic cancer"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in radiation therapy of pancreatic cancer </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=17772 data-id=16272 data-downloads="" data-views="" data-scholar="10.12688/f1000research.16272.1" data-recommended="" data-doi="10.12688/f1000research.16272.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-1931/v1/pdf?article_uuid=c14c0f99-905c-4b3b-93f4-9432f9f5896f" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-16272-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-16272-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-16272-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Venkatesulu BP, Hsieh CE, Sanders KL and Krishnan S. Recent advances in radiation therapy of pancreatic cancer [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1931 (<a class=new-orange href="https://doi.org/10.12688/f1000research.16272.1" target=_blank>https://doi.org/10.12688/f1000research.16272.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-16272-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=16272 id=track-article-signin-16272 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/16272?target=/articles/7-1931">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=17772 /> <input name=articleId type=hidden value=16272 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in radiation therapy of pancreatic cancer</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Bhanu Prasad Venkatesulu<sup>1</sup>,&nbsp;</span><span class="">Cheng-En Hsieh<sup>1-4</sup>,&nbsp;</span><span class="">Keith L Sanders<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:SKrishnan@mdanderson.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Sunil Krishnan</span></a><a href="https://orcid.org/0000-0002-1340-4771" target=_blank id=author-orcid-3><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-3><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-1340-4771</div><sup>1-3</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Bhanu Prasad Venkatesulu<sup>1</sup>,&nbsp;</span><span class="">Cheng-En Hsieh<sup>1-4</sup>,&nbsp;</span><span class="">Keith L Sanders<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:SKrishnan@mdanderson.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Sunil Krishnan</span></a><a href="http://orcid.org/0000-0002-1340-4771" target=_blank id=mauthor-orcid-3><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-3><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-1340-4771</div><sup>1-3</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 13 Dec 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.16272.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA<br/> <sup>2</sup> Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA<br/> <sup>3</sup> The University of Texas MD Anderson Cancer Center-UT Health Graduate School of Biomedical Sciences, Houston, TX, USA<br/> <sup>4</sup> Department of Radiation Oncology, Chang Gung Memorial Hospital, Linkou and Chang Gung University, Taoyuan, Taiwan<br/> <p> <div class=margin-bottom> Bhanu Prasad Venkatesulu <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Cheng-En Hsieh <br/> <span>Roles: </span> Investigation, Methodology, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Keith L Sanders <br/> <span>Roles: </span> Investigation, Methodology, Writing  Review & Editing </div> <div class=margin-bottom> Sunil Krishnan <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Supervision, Writing  Original Draft Preparation, Writing  Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=43003-41753></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=43002-41754></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Pancreatic cancer has a dismal prognosis with an overall survival outcome of just 5% at five years. However, paralleling our improved understanding of the biology of pancreatic cancer, treatment paradigms have also continued to evolve with newer advances in surgical techniques, chemotherapeutic agents, radiation therapy (RT) techniques, and immunotherapy paradigms. RT dose, modality, fraction size, and sequencing are being evaluated actively, and the interplay between RT and immune effects has opened up newer avenues of research. In this review, we will emphasize recent advances in RT for pancreatic cancer, focusing on preoperative chemoradiation, RT dose escalation, sparing of the spleen to reduce lymphopenia, and combination of RT with immunotherapy. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Dose escalation, immunotherapy, neoadjuvant therapy, spleen sparing, radiotherapy </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Sunil Krishnan (<a href="mailto:SKrishnan@mdanderson.org">SKrishnan@mdanderson.org</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Sunil Krishnan </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This study was supported in part by the MD Anderson Cancer Center support grant P30 CA16672 and funding from the John E. and Dorothy J. Harris Endowed Professorship and U01CA216468 (to SK). <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2018 Venkatesulu BP <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Venkatesulu BP, Hsieh CE, Sanders KL and Krishnan S. Recent advances in radiation therapy of pancreatic cancer [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1931 (<a href="https://doi.org/10.12688/f1000research.16272.1" target=_blank>https://doi.org/10.12688/f1000research.16272.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 13 Dec 2018, <b>7</b>(F1000 Faculty Rev):1931 (<a href="https://doi.org/10.12688/f1000research.16272.1" target=_blank>https://doi.org/10.12688/f1000research.16272.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 13 Dec 2018, <b>7</b>(F1000 Faculty Rev):1931 (<a href="https://doi.org/10.12688/f1000research.16272.1" target=_blank>https://doi.org/10.12688/f1000research.16272.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d19341e216>Introduction</h2><p class="" id=d19341e219>Pancreatic cancer is the second most common gastrointestinal cancer in the United States, where there was an estimated incidence of 53,070 cases in 2016<sup><a href="#ref-1">1</a></sup>. Survival outcomes are dismal with a reported five-year overall survival (OS) rate of less than 5%<sup><a href="#ref-2">2</a></sup>. Radiation therapy (RT) is an integral component of the arsenal against pancreatic cancer and is frequently used in the neoadjuvant, adjuvant, and palliative settings. In an ever-changing landscape of treatment options for pancreatic cancer, some patterns are emerging that bear upon the utilization of RT in this disease. A recent autopsy study concluded thatindependent of initial clinical stage, histological features, and treatment course30% of patients die with locally destructive pancreatic cancer whereas 70% die with distant metastatic disease<sup><a href="#ref-3">3</a></sup>. Patients in this sizeable subset tend to lack inactivation of their <i>DPC4</i> gene and may benefit considerably from intensified treatment with a local treatment modality. In agreement with this, post-pancreatectomy patterns-of-recurrence studies have shown that patients most commonly (about 5060%) recur systemically but that a large subset recur locally (2025%) or both locally and distantly (1520%). Again, local treatment modalities may play a significant role in minimizing local recurrence, and a greater understanding of biological predictors of varied patterns of recurrence should help elucidate potential ways to reduce the risk of recurrence<sup><a href="#ref-4">4</a><a href="#ref-6">6</a></sup>. Although these studies suggest that there is a role for local treatment intensification, there is little agreement on whether RT improves survival in patients by addressing this local recurrence risk, when this should be administered, how it is best administered, and what other principles dictate efficacy of treatment<sup><a href="#ref-7">7</a><a href="#ref-9">9</a></sup>. We address these gaps in knowledge in the next few sections and highlight advances in our understanding of the role of radiotherapy in pancreatic cancer.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d19341e255>Defining a borderline resectable pancreatic cancer subset</h2><p class="" id=d19341e258>Historically, localized non-metastatic pancreatic cancers were categorized as locally advanced or resectable on the basis of the likelihood of major vascular involvement on radiographic studies that dictated whether or not a margin-negative R0 resection was feasible. Radiographic assessment sheds light on involvement of the retroperitoneal marginsuperior mesenteric artery (SMA) and superior mesenteric vein (SMV)as well as that of the celiac artery and confluence of the SMV and the portal vein (PV). More recently, a new category of borderline resectable pancreatic cancer (BRPC) has been created wherein there is some degree of involvement of vascular structures that could compromise achievement of an R0 resection. A number of groups have tried to define criteria for resectability<sup><a href="#ref-10">10</a>,<a href="#ref-11">11</a></sup>. The consensus includes anatomic criteria such as feasibility of reconstruction of SMV-PV confluence, less than 180 involvement of the SMA and celiac axis, and common hepatic artery origin from celiac axis that can be reconstructed. Some groups also include in this category patients with uncertainty regarding metastatic stage usually arising from indeterminate distant lesions on radiographic studies and poor performance status that would preclude immediate surgery<sup><a href="#ref-11">11</a></sup>.</p><p class="" id=d19341e272>The creation of a category of BRPC dovetails with the recognition that the technically challenging nature of resection along the retroperitoneal margin results in patients frequently undergoing an incomplete (margin-positive) resection<sup><a href="#ref-12">12</a><a href="#ref-18">18</a></sup>. In many studies, resection margin statusin addition to tumor size, stage, and gradeis considered an important predictor of early recurrence and inferior survival rates<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a>,<a href="#ref-18">18</a><a href="#ref-22">22</a></sup>. This poor survival rate<sup><a href="#ref-20">20</a>,<a href="#ref-23">23</a>,<a href="#ref-24">24</a></sup> closely mimics that of patients with locally advanced pancreatic cancer (LAPC)<sup><a href="#ref-25">25</a></sup>. Furthermore, postoperative chemoradiation therapy (CRT) does not overcome the unfavorable prognosis conferred by a margin-positive resection<sup><a href="#ref-12">12</a>,<a href="#ref-14">14</a></sup>. Therefore, leaving behind a positive margin at surgery is essentially akin to not having undergone surgery at all since the survival outcomes are no better than those of LAPC patients who did not undergo surgical resection in the first place<sup><a href="#ref-12">12</a>,<a href="#ref-14">14</a>,<a href="#ref-20">20</a>,<a href="#ref-23">23</a><a href="#ref-25">25</a></sup>. Notably, during the recovery time from this surgery, patients are unable to receive chemotherapy or RT, further hampering early and effective disease control locally and distantly. Recognizing the detrimental effect of margin-positive resections and creating a BRPC category allow better selection of patients for surgical resection. Importantly, they also offer the opportunity to deliver some neoadjuvant therapy to patients with BRPC to make them potentially resectable and to reduce the likelihood that this resection will be a margin-positive R1 resection.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d19341e336>Preoperative chemoradiation</h2><p class="" id=d19341e339>Preoperative therapy has been explored by a number of groups in both potentially resectable pancreatic cancer and BRPC. While the optimal treatment approaches for all categories of non-metastatic pancreatic cancer remain controversial, for BRPC, the most compelling argument for neoadjuvant therapy is to convert them to potentially resectable tumors by sterilizing the retroperitoneal margin. For potentially resectable pancreatic cancers, a number of arguments can be made for neoadjuvant therapy. In pancreatic cancers, as in other cancers where preoperative therapy is used routinely (rectal and esophageal)<sup><a href="#ref-26">26</a>,<a href="#ref-27">27</a></sup>, preoperative treatment allows (a) better tissue penetration of drug and oxygen, resulting in greater response to chemotherapy and radiotherapy, respectively; (b) greater chances of an R0 resection (since even potentially resectable pancreatic cancers that go to surgery upfront often encounter positive margins and perineural invasion); (c) better outcomes even if the resection ends up being R1<sup><a href="#ref-28">28</a></sup>; (d) lower risk of anastomotic leaks at the pancreaticojejunostomy site because of firmer post-radiation pancreatic tissue that sutures go through<sup><a href="#ref-29">29</a><a href="#ref-31">31</a></sup>; and (e) the ability to select patients who pass the stress test of neoadjuvant treatment satisfactorily and do not develop interval metastases or newly diagnosed, previously occult metastatic disease (both good performance status and true non-metastatic localized disease serving as clinical indicators of a favorable biology). By relegating the most challenging treatment (that is, surgery) to the end of the treatment course, this approach also ensures a high probability of patients receiving all three components of treatment (surgery, chemotherapy, and radiotherapy) rather than suffer from delays in or abandonment of treatment (2030% of patients are unable to receive planned postoperative therapy) because of prolonged recovery times from surgery or new metastatic disease manifesting itself during the recovery periods<sup><a href="#ref-32">32</a></sup>.</p><p class="" id=d19341e364>A number of phase II studies have evaluated the role of CRT in the neoadjuvant setting for potentially resectable pancreatic cancer. A meta-analysis<sup><a href="#ref-33">33</a></sup> noted that neoadjuvant therapy for initially resectable tumors resulted in a 4% complete radiographic or pathologic response rate, 31% partial radiographic or pathologic response rate, 74% resectability, and a median OS of 23.3 months, which is similar to that of patients who undergo surgery upfront. In the first prospective randomized phase II trial, the German investigators compared surgery followed by six cycles of gemcitabine to neoadjuvant gemcitabine, cisplatin, and RT (50.4 Gy to the regional nodes and 55.8 Gy to the tumor) followed by surgery and six cycles of adjuvant gemcitabine chemotherapy. The study was terminated early after enrollment of only a quarter of planned patients because of slow accrual but noted a median OS of 17.4 months with neoadjuvant CRT compared with 14.4 months with adjuvant chemotherapy arm (<i>P</i> = 0.96) with comparable R0 and pN0 resections in both arms<sup><a href="#ref-34">34</a></sup>. When patients with BRPC are also included, the potential benefit of neoadjuvant therapy seems to be more apparent, as was hinted at in the meta-analysis above. The meta-analysis noted that, for initially unresectable BRPC and LAPC, neoadjuvant therapy resulted in 5% radiographic or pathologic complete response rate, 30% partial response rate, 33% resectability, and a median OS of 20.5 months, which is comparable to that of initially resectable patients.</p><p class="" id=d19341e378>Early results of the multi-center randomized phase III PREOPANC-1 study presented recently at the American Society of Clinical Oncology 2018 annual meeting compared preoperative CRT with adjuvant chemotherapy in 246 patients, split nearly evenly between BRPC and potentially resectable patients<sup><a href="#ref-35">35</a></sup>. The preoperative therapy arm received a cycle of gemcitabine followed by gemcitabine and RT (36 Gy in 15 fractions) and another cycle of gemcitabine before surgery and four cycles of postoperative gemcitabine, whereas the adjuvant chemotherapy arm received six cycles of gemcitabine. Preoperative treatment resulted in improved median OS (17.1 versus 13.5 months, <i>P</i> = 0.74) and greater time to recurrence (9.9 versus 7.9 months, <i>P</i> = 0.023) and R0 resection rate (63% versus 31%, <i>P</i> &lt;0.001) without any difference in toxicity profiles. Notably, among patients who underwent surgery, the median OS was significantly better in the neoadjuvant arm than in the adjuvant arm (29.9 versus 16.8 months, <i>P</i> &lt;0.001). Although these results are promising and suggest that patients with BRPC should receive neoadjuvant therapy followed by re-evaluation for resectability, the ideal approach would be to treat patients on protocols to establish the value of neoadjuvant therapy more objectively. One such study that is accruing currently is the randomized phase II Alliance for Clinical Oncology trial (A021501) where patients with BRPC receive FOLFIRINOX (oxaliplatin, irinotecan, leucovorin, and infusional 5-fluorouracil) alone or FOLFIRINOX followed by stereotactic body RT (SBRT) of 3340 Gy in five fractions before surgery<sup><a href="#ref-36">36</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d19341e405>Radiation dose escalation in pancreatic cancer</h2><p class="" id=d19341e408>Radiation dose escalation has been studied the most in LAPC where treatment outcomes are poorer than for resectable and borderline resectable patients and the likelihood of conversion to resectability is low. The randomized phase III LAP-07 trial showed that CRT of 54 Gy with gemcitabine after 4 months of gemcitabine-based chemotherapy did not provide an OS benefit compared with 6 months of chemotherapy alone in LAPC but CRT was associated with reduced local progression (32% versus 46%, <i>P</i> = 0.03). The findings of this study suggest that standard-dose RT produces good local control but treatment intensification may be warranted to improve OS<sup><a href="#ref-37">37</a></sup>. Treatment intensification could be achieved via more potent chemotherapy such as FOLFIRINOX or gemcitabine-Nab-paclitaxel or via radiation dose escalation. As systemic therapy becomes more effective, the local failure may become a cause for greater concern if it exceeds the nearly 30% of patients who were noted to die with locally destructive pancreatic cancer in the autopsy series described previously.</p><p class="" id=d19341e418>A viable option for improving local control is to escalate the dose of RT to the tumor while respecting normal tissue dose constraints. This can be accomplished via standard courses of fractionated RT of about five weeks with incremental increases in dose-per-fraction to the planning target volume with the option of an integrated boost to the gross tumor volume typically achieved with intensity-modulated RT (IMRT) or via SBRT, where higher doses of radiation are administered to small tumor volumes with precise image guidance and motion management. <a href="#f1">Figure 1</a> highlights a patient who had dose escalation of 70 Gy to the gross tumor volume through IMRT. In both instances, the close proximity of gastrointestinal mucosa (stomach, duodenum, and jejunum) precluded excessive dose escalation. In a phase III randomized French study, gemcitabine alone was compared with 5-fluorouracil, cisplatin, and 60 Gy of RT to a large pancreatic field followed by gemcitabine<sup><a href="#ref-38">38</a></sup>. The chemotherapy-alone arm fared better with a median OS of 13 months compared with 8.6 months (<i>P</i> = 0.03) but was also significantly less toxic. The unusually low OS on the CRT arm indicated that radiation dose escalation is potentially deleterious if performed without image guidance and if combined with overly intensive chemotherapy. On the other hand, Chung <i>et al</i>. reported that dose escalation of more than 61 Gy leads to better one-year OS and progression-free survival (PFS)<sup><a href="#ref-39">39</a></sup>. Krishnan <i>et al</i>. reported that patients who received a biologically equivalent dose (BED) greater than 70 Gy had superior OS (17.8 versus 15 months, <i>P</i> = 0.03) as well as better local PFS (10.2 versus 6.2 months, <i>P</i> = 0.05) compared with those receiving BED of less than 70 Gy<sup><a href="#ref-40">40</a></sup>. It is noteworthy that this trial reported outcomes from the start of RT and not from the date of diagnosis and yet the high BED cohort had a remarkable three-year OS of 31%. Admittedly, this was possible in only a subset of patients whose tumors were at least 1 cm away from bowel mucosa and required daily image guidance, motion tracking and control, and maintenance of an empty stomach for 3 hours before treatment in the majority of patients. Most patients did not require fiducial placement since daily volumetric imaging was available on a CT-on-rails. With similar attention to organ motion and image guidance, the other approach that is convenient and easily incorporated into the overall management plan of patients is SBRT in which a high BED can be administered in a short duration. Again, respecting bowel mucosal constraints is critical since this is an organ with serial functional subunits (like the spinal cord) and excessive dose to even a small volume could result in significant functional compromise and toxicity. With gentler fractionation of five fractions, a moderate dose of 33 Gy has now been safely administered to a large number of patients. A multi-institutional phase II study demonstrated that gemcitabine with SBRT of 33 Gy in five fractions over the course of one week is safe and technically feasible in LAPC<sup><a href="#ref-41">41</a></sup>. As noted above, the Alliance for Clinical Oncology Trial A021501 seeks to gently increase the radiation dose up to 40 Gy in five fractions in patients with BRPC, bringing it closer to ablative doses of radiation used in the treatment of liver tumors<sup><a href="#ref-36">36</a></sup>. By intensifying the systemic therapy as well as the local therapy, this trial will address both causes of failure in patients.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/17772/5f183cba-5f16-42b6-be60-2deaafce8e5d_figure1.gif"><img alt="5f183cba-5f16-42b6-be60-2deaafce8e5d_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/17772/5f183cba-5f16-42b6-be60-2deaafce8e5d_figure1.gif"></a><div class=caption><h3>Figure 1. Representative images and treatment plan for dose-escalated radiation therapy for pancreatic cancer.</h3><p id=d19341e470>Axial (<b>a</b>), sagittal (<b>b</b>), and coronal (<b>c</b>) view of a patient who received 50.4 Gy in 28 fractions to the planning target volume with simultaneous integrated boost of 55 Gy to the clinical target volume and 70 Gy boost to the gross tumor volume. (<b>d</b>) Dose volume histogram of the targets and organs at risk. This figure was produced by SK, (<b>a</b>), (<b>b</b>) and (<b>c</b>) uses original images taken in SKs clinic for this publication.</p></div></div><p class="" id=d19341e499>An alluring option that is worth considering is that of being less stringent with defining who proceeds to surgery after neoadjuvant CRT. For instance, among the first large reports of BRPC treatment with preoperative CRT, only 41% of 160 patients who completed preoperative therapy and restaging advanced to pancreatectomy, 94% of which were margin-negative pancreatectomies<sup><a href="#ref-42">42</a></sup>. One could argue that the very low rates of margin positivity suggest that resectability criteria are too stringent. More recently, it was noted that neoadjuvant FOLFIRINOX did not convert locally advanced and borderline resectable patients to resectable by radiographic criteria in a majority of patients; even so, when taken to surgery, the R0 resection rate was 92%<sup><a href="#ref-43">43</a></sup>. This suggests that traditional radiological criteria for resectability may overestimate the likelihood of margin positivity and that adoption of less stringent criteria may increase the number of patients going to surgery without a large increase in margin positivity. Extended to its logical conclusion, this conjecture would result in a three-pronged fork in the road after completion of CRT. The first prong (say, the good) would be those patients with clear traditional radiological criteria for resectability who would go to surgery. The second (say, the bad) would be those patients with traditional radiological criteria that would not warrant surgery but there are no adverse factors such as worsening performance status, questionable new metastases, unexplained tumor marker increase, or complete encasement of celiac axis or SMA. They merely have involvement of the SMA or celiac axis that precludes resectability by traditional radiological criteria. These patients would undergo reimaging in a couple of months and, if all criteria remain unchanged, would undergo surgery with an implicit acceptance of a higher likelihood of R1 resections. The third (say, the ugly) would be patients with encasement of vessels, worsening performance status, questionable new metastases, and rising tumor markers. These patients would not go to surgery. While treatment paradigms are slowly shifting in this direction for BRPC, such a trend is lacking in LAPC. Treatment of patients on protocols may help define the value of such an approach more objectively.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d19341e513>Spleen as a dose-limiting organ in pancreatic cancer radiotherapy</h2><p class="" id=d19341e516>A preponderance of evidence suggests that lymphopenia, especially that following RT, confers a poor prognosis in the treatment of a variety of cancers<sup><a href="#ref-44">44</a></sup>. This was also observed in pancreatic cancer in a study from Johns Hopkins University where post-treatment lymphopenia correlated with increased mortality in resectable pancreatic cancer and LAPC. RT toxicity to circulating lymphocytes was postulated as the likely cause of lymphopenia that was independent of chemotherapy usage. Mortality was reported to be due to tumor progression rather than lymphopenia-related opportunistic infections<sup><a href="#ref-45">45</a>,<a href="#ref-46">46</a></sup>. A report from the MD Anderson Cancer Center also demonstrated that post-CRT lymphopenia occurred in roughly a third of all patients with LAPC and was strongly associated with poor survival outcomes. Importantly, however, the dose to the spleen (mean dose exceeding 9 Gy and V15 exceeding 20%) was an independent predictor of post-CRT lymphopenia, suggesting that the detrimental effect of lymphopenia is potentially minimized by sparing the spleen<sup><a href="#ref-47">47</a></sup>. The spleen routinely receives unintentional radiation dose while irradiating pancreatic cancers not only because it lies in close proximity to the pancreas but also because it is not commonly viewed as a dose-limiting organ while developing treatment plans. However, it is a rich reservoir of T and B lymphocytes that slowly traverse through the sinusoidal architecture of flow channels within it, allowing ample time for collateral radiation injury during each fraction of treatment. Conceivably, this depletion of resident or slow-moving lymphocytes in the spleen could also reduce the levels of CD8<sup>+</sup> cytotoxic T lymphocytes and CD4<sup>+</sup> helper T cells available for tumor infiltration. In turn, this could adversely impact OS outcomes as noted in surgical series where less tumor infiltration with CD8<sup>+</sup> T cells is associated with poorer OS<sup><a href="#ref-48">48</a>,<a href="#ref-49">49</a></sup> and reduce the effectiveness of future potential immunotherapies that rely on the presence of a pool of healthy lymphocytes for activation and tumor homing<sup><a href="#ref-50">50</a></sup>. Of note, tumor size, field size, irradiated volume (encompassed by the 50% isodose line), and treated volume (encompassed by the 95% isodose line) did not independently predict the likelihood of developing lymphopenia, suggesting that depletion of circulating lymphocytes may not be a dominant mechanism of developing lymphopenia in patients with pancreatic cancer.</p><p class="" id=d19341e555>The correlation between splenic dose and lymphopenia needs to be independently validated in other series. However, since it is unlikely that prospective studies will establish the clinical benefit of spleen-sparing RT for pancreatic cancer, treatment plans could be readily triaged on the basis of their ability to adequately spare the spleen. In patients most vulnerable to developing lymphopenia or having poor outcomes from lymphopenia such as patients with baseline lymphopenia prior to initiating CRT, patients who are candidates for immunotherapy, and patients being considered for RT dose escalation protocols, one could consider using spleen-sparing beam angles for three-dimensional conformal RT, IMRT, increased dose rates for beam delivery, charged particle therapy, and SBRT<sup><a href="#ref-51">51</a>,<a href="#ref-52">52</a></sup>. More refined normal tissue complication probability modeling may also serve as a predictive tool to spatially correlate splenic dose volume histograms with lymphopenia.</p><p class="" id=d19341e565>Alternatively, strategies could be developed to replenish or protect lymphocytes (or both) from damage mediated by RT. Preclinical models have demonstrated that interleukin-7 (IL-7) and IL-15 administration to irradiated mice resulted in greater tumor regression which was associated with an increase in CD8<sup>+</sup> cytotoxic T cell counts without an increase in immunosuppressive regulatory T cell counts<sup><a href="#ref-53">53</a><a href="#ref-55">55</a></sup>. A phase I clinical trial is exploring IL-7 administration in high-grade glioma patients who develop lymphopenia after completion of CRT<sup><a href="#ref-56">56</a></sup>. IL-15 is being evaluated as monotherapy in metastatic melanoma and renal cell carcinoma, albeit not for lymphopenia<sup><a href="#ref-57">57</a></sup>. It would be worthwhile to evaluate the role of IL-15 as a rescue agent for lymphopenia following RT. Lymphocyte reconstitution is frequently used as a rescue strategy following myeloablative chemotherapy and RT in transplant protocols and adoptive T-cell therapy<sup><a href="#ref-58">58</a></sup>. In one study, autologous lymphocytes harvested before temozolomideRT for high-grade gliomas were reinfused after completion of treatment. However, the return of lymphocyte counts following radiation-induced depletion was no different between reinfused patients and matched controls<sup><a href="#ref-59">59</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d19341e599>Immunotherapy with radiation in pancreatic cancer</h2><p class="" id=d19341e602>Consistent with the notion that lymphocytes play a crucial role in determining treatment outcomes of these patients, pancreatic cancer has also been the focus of immuno-oncology studies aimed at arousing the immune system to combat cancer progression and metastasis. However, pancreatic cancer poses a unique challenge to immunotherapy because of the presence of a thick fibrous capsule with intense desmoplastic stroma that counteracts the entry of immune cells. In addition, the pancreatic tumor milieu has a preponderance of regulatory T cells, myeloid-derived suppressor cells, and M2 macrophages that contribute to the immunosuppressive tumor microenvironment<sup><a href="#ref-60">60</a></sup>. Pancreatic cancer tends to produce IL-10, transforming growth factor-beta (TGF-), and increased expression of programmed death-ligand 1 (PD-L1) that prevents activation of tumor antigen-specific T cells.</p><p class="" id=d19341e609>Nevertheless, accumulating evidence of a synergy between immunotherapy and radiotherapy has resulted in enormous growth of this area as a promising and exciting avenue of research. Herein, RT is seen as serving as an <i>in situ</i> vaccine via release of autoantigens and radiation-induced neoantigens that are displayed to antigen-presenting cells that then cross-present tumor antigen to prime T cells to mount a cytotoxic tumor-specific immune response. RT triggers the elaboration of a damage-associated molecular pattern (DAMP) response wherein cells display hallmarks of the eat me phenotype that leads to phagocytosis by antigen-presenting cells. In turn, these antigen presenting cells cross-present tumor antigens to T cells which enable immune-mediated tumor killing<sup><a href="#ref-61">61</a></sup>. But RT can also be immunosuppressive by upregulating the expression of death receptors and immune checkpoint proteins that drive co-inhibitory pathways to evade immune eradication. Also, RT can induce lymphocyte apoptosis via secretion of galectin-1 by tumors and lead to secretion of TGF- into the tumor microenvironment, thereby hindering the ability to mount an effective cytotoxic T-cell response to tumor antigens<sup><a href="#ref-62">62</a><a href="#ref-64">64</a></sup>. Careful tuning of this balance between immunostimulatory and immunosuppressive effects of radiation can lead to a dominance of immune stimulation and immune-mediated tumor eradication. Preclinical studies suggest that an ablative dose of RT has the potential for potent T-cell priming in draining lymph nodes, facilitation of increased antigen presentation, activation of immune responserelated genes, radiation-induced DAMP molecules, and increased release of inflammatory cytokines.</p><p class="" id=d19341e626>SBRT may have a unique role in synergizing with immunotherapy because the high dose induces a dominant <i>in situ</i> vaccination effect and the small number of fractions leads to less depletion of primed and activated cytotoxic T cells returning to the tumor<sup><a href="#ref-65">65</a></sup>. Currently, over 30 clinical trials are evaluating immunotherapy in pancreatic cancer. Algenpantucel-L is an alpha-1, 3-galactosyl transferaseexpressing allogeneic pancreatic tumor cell vaccine that is supposed to cause rapid activation of antibody-dependent cell-mediated cytotoxicity (toward pancreatic cancer cells). GVAX is a cancer vaccine that has been genetically modified to produce granulocyte-macrophage colony-stimulating factor (GM-CSF) that induces a robust T-cell response. Both of these agents are being evaluated with SBRT<sup><a href="#ref-66">66</a>,<a href="#ref-67">67</a></sup>. Losartan, via inhibition of the renin-angiotensin system, downregulates TGF- activity, thereby facilitating intratumoral penetration of drugs by stromal and vascular remodeling. Studies are evaluating the combination of losartan and PD-L1 blockade with SBRT. Other studies are exploring the combination of immune checkpoint inhibitorsantibodies to cytotoxic T lymphocyteassociated protein 4 (CTLA-4) and PD-L1with SBRT and chemotherapy to find the optimal combination that generates durable treatment responses and improved OS<sup><a href="#ref-68">68</a><a href="#ref-71">71</a></sup>. Although immunotherapy holds promise in pancreatic cancer, pragmatic clinical trials with optimal sequencing of immunotherapy and RT are needed<sup><a href="#ref-72">72</a></sup>. Finding innovative ways to enhance the permeability of the pancreatic cancer stromal matrix for efficient drug delivery may hold the key to enhancing the effect of immunotherapy, especially because metastases are as stroma-rich as the primary tumor<sup><a href="#ref-73">73</a></sup>; radiation may play a role in magnifying the role of immunotherapeutic agents through judicious elaboration of its <i>in situ</i> vaccine effect. <a href="#T1">Table 1</a> summarizes the currently active clinical trials that combine radiotherapy with immunotherapy in pancreatic cancer.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Summary of the currently active clinical trials that are ongoing that combine radiation with immunotherapy in pancreatic cancer.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d19341e676 class=n-a></a><thead><a name=d19341e678 class=n-a></a><tr><a name=d19341e680 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d19341e682 class=n-a></a>ClinicalTrials.gov<br class=br>Identifier</th><th align=left colspan=1 rowspan=1 valign=top><a name=d19341e687 class=n-a></a>Phase</th><th align=left colspan=1 rowspan=1 valign=top><a name=d19341e690 class=n-a></a>Title</th><th align=left colspan=1 rowspan=1 valign=top><a name=d19341e693 class=n-a></a>Intervention</th><th align=left colspan=1 rowspan=1 valign=top><a name=d19341e696 class=n-a></a>Radiation<br class=br>detail</th><th align=left colspan=1 rowspan=1 valign=top><a name=d19341e702 class=n-a></a>Disease stage</th></tr></thead><tbody><a name=d19341e707 class=n-a></a><tr><a name=d19341e709 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e711 class=n-a></a>NCT02648282</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e714 class=n-a></a>2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e717 class=n-a></a>Study With CY, Pembrolizumab,<br class=br>GVAX, and SBRT in Patients With<br class=br>Locally Advanced Pancreatic<br class=br>Cancer</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e726 class=n-a></a>Cyclophosphamide<br class=br>GVAX<br class=br>Pembrolizumab</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e733 class=n-a></a>6.6 Gy per day<br class=br>over the course<br class=br>of 5 days</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e741 class=n-a></a>Locally advanced pancreatic<br class=br>cancer</td></tr><tr><a name=d19341e747 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e749 class=n-a></a>NCT03104439</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e752 class=n-a></a>2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e755 class=n-a></a>Nivolumab and Ipilimumab<br class=br>and Radiation Therapy in MSS<br class=br>and MSI High Colorectal and<br class=br>Pancreatic Cancer</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e764 class=n-a></a>Nivolumab<br class=br>Ipilimumab</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e769 class=n-a></a>8 Gy per day<br class=br>over the course<br class=br>of 3 days</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e777 class=n-a></a>Oligometastatic pancreatic<br class=br>cancer</td></tr><tr><a name=d19341e783 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e785 class=n-a></a>NCT03161379</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e788 class=n-a></a>2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e791 class=n-a></a>Phase 2 GVAX Pancreas Vaccine<br class=br>(With CY) in Combination With<br class=br>Nivolumab and SBRT for Patients<br class=br>With Borderline Resectable<br class=br>Pancreatic Cancer</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e802 class=n-a></a>Cyclophosphamide<br class=br>Nivolumab<br class=br>GVAX </td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e809 class=n-a></a>6.6 Gy per day<br class=br>over the course<br class=br>of 5 days</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e817 class=n-a></a>Borderline Resectable<br class=br>Pancreatic Adenocarcinoma</td></tr><tr><a name=d19341e823 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e825 class=n-a></a>NCT02305186</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e828 class=n-a></a>1/2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e831 class=n-a></a>Safety and Immunological Effect<br class=br>of Pembrolizumab in Resectable<br class=br>or Borderline Resectable<br class=br>Pancreatic Cancer (UVA-PC-<br class=br>PD101)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e842 class=n-a></a>Pembrolizumab<br class=br>Capecitabine</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e847 class=n-a></a>50.4 Gy in 28<br class=br>fractions over<br class=br>the course of 28<br class=br>days</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e857 class=n-a></a>Resectable or Borderline<br class=br>Resectable Pancreatic<br class=br>Cancer</td></tr><tr><a name=d19341e865 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e867 class=n-a></a>NCT03563248</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e870 class=n-a></a>2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e873 class=n-a></a>Losartan and Nivolumab in<br class=br>Combination With FOLFIRINOX<br class=br>and SBRT in Localized<br class=br>Pancreatic Cancer</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e882 class=n-a></a>5-Fluorouracil Oxaliplatin<br class=br>Irinotecan<br class=br>Leucovorin<br class=br>Losartan<br class=br>Nivolumab</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e893 class=n-a></a>SBRT</td><td align=left colspan=1 rowspan=1 valign=top><a name=d19341e897 class=n-a></a>Borderline/potentially<br class=br>resectable or locally<br class=br>advanced.</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d19341e909 class=n-a></a><p id=d19341e911> CY, cyclophosphamide; GVAX, granulocyte-macrophage colony-stimulating factor (GM-CSF) gene-transfected tumor cell vaccine; MSI, microsatellite instable; MSS, microsatellite stable; SBRT, stereotactic body radiotherapy.</p></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d19341e920>Conclusions</h2><p class="" id=d19341e923>Exciting new clinical research suggests that the outcomes in pancreatic cancer can be improved by a multi-pronged approach. Careful stratification of patients into distinct categories, adoption of neoadjuvant therapy for resectable and borderline resectable categories, judicious focal dose escalation with image guidance and motion management, avoidance of splenic irradiation to reduce lymphopenia, and potentially the combination of RT with immunotherapeutic agents may all have a role in the optimal management of pancreatic cancer with RT in the future. For now, these approaches address critical challenges faced while considering RT during the treatment of pancreatic cancer and only continued evaluation of such strategies on clinical trials will address persisting gaps in knowledge.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d19341e1 class=n-a></a><h2 class=main-title id=d19557>Grant information</h2><p>This study was supported in part by the MD Anderson Cancer Center support grant P30 CA16672 and funding from the John E. and Dorothy J. Harris Endowed Professorship and U01CA216468 (to SK).</p><p><i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i></p></div><div class=back-section><a name=d19341e930 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d19797>References</h2><div class="section ref-list"><a name=d19341e930 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726071516"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d19341e937 class=n-a></a>Siegel RL, Miller KD, Jemal A: Cancer statistics, 2016. <i>CA Cancer J Clin.</i> 2016; <b>66</b>(1): 730. <a target=xrefwindow id=d19341e945 href="http://www.ncbi.nlm.nih.gov/pubmed/26742998">PubMed Abstract </a> | <a target=xrefwindow id=d19341e948 href="https://doi.org/10.3322/caac.21332">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726071516">F1000 Recommendation</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d19341e961 class=n-a></a>Hidalgo M: Pancreatic cancer. <i>N Engl J Med.</i> 2010; <b>362</b>(17): 160517. <a target=xrefwindow id=d19341e969 href="http://www.ncbi.nlm.nih.gov/pubmed/20427809">PubMed Abstract </a> | <a target=xrefwindow id=d19341e972 href="https://doi.org/10.1056/NEJMra0901557">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d19341e981 class=n-a></a>Iacobuzio-Donahue CA, Fu B, Yachida S, <i> et al.</i>: DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. <i>J Clin Oncol.</i> 2009; <b>27</b>(11): 180613. <a target=xrefwindow id=d19341e992 href="http://www.ncbi.nlm.nih.gov/pubmed/19273710">PubMed Abstract </a> | <a target=xrefwindow id=d19341e995 href="https://doi.org/10.1200/JCO.2008.17.7188">Publisher Full Text </a> | <a target=xrefwindow id=d19341e999 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2668706">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d19341e1008 class=n-a></a>Sperti C, Pasquali C, Piccoli A, <i> et al.</i>: Recurrence after resection for ductal adenocarcinoma of the pancreas. <i>World J Surg.</i> 1997; <b>21</b>(2): 195200. <a target=xrefwindow id=d19341e1019 href="http://www.ncbi.nlm.nih.gov/pubmed/8995078">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1022 href="https://doi.org/10.1007/s002689900215">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d19341e1031 class=n-a></a>Van den Broeck A, Sergeant G, Ectors N, <i> et al.</i>: Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. <i>Eur J Surg Oncol.</i> 2009; <b>35</b>(6): 6004. <a target=xrefwindow id=d19341e1042 href="http://www.ncbi.nlm.nih.gov/pubmed/19131205">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1045 href="https://doi.org/10.1016/j.ejso.2008.12.006">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727437293"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d19341e1055 class=n-a></a>Groot VP, Rezaee N, Wu W, <i> et al.</i>: Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma. <i>Ann Surg.</i> 2018; <b>267</b>(5): 93645. <a target=xrefwindow id=d19341e1066 href="http://www.ncbi.nlm.nih.gov/pubmed/28338509">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1069 href="https://doi.org/10.1097/SLA.0000000000002234">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727437293">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d19341e1082 class=n-a></a>Chadha AS, Khoo A, Aliru ML, <i> et al.</i>: Recent Advances and Prospects for Multimodality Therapy in Pancreatic Cancer. <i>Semin Radiat Oncol.</i> 2016; <b>26</b>(4): 32037. <a target=xrefwindow id=d19341e1093 href="http://www.ncbi.nlm.nih.gov/pubmed/27619253">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1096 href="https://doi.org/10.1016/j.semradonc.2016.05.002">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d19341e1105 class=n-a></a>Krishnan S, Ahmad M: Intensifying local radiotherapy for pancreatic cancer-who benefits and how do we select them? <i>J Gastrointest Oncol.</i> 2013; <b>4</b>(4): 3379. <a target=xrefwindow id=d19341e1113 href="http://www.ncbi.nlm.nih.gov/pubmed/24294503">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1116 href="https://doi.org/10.3978/j.issn.2078-6891.2013.027">Publisher Full Text </a> | <a target=xrefwindow id=d19341e1119 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3819774">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d19341e1128 class=n-a></a>Krishnan S, Rana V, Janjan NA, <i> et al.</i>: Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy. <i>Cancer.</i> 2007; <b>110</b>(1): 4755. <a target=xrefwindow id=d19341e1139 href="http://www.ncbi.nlm.nih.gov/pubmed/17538975">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1142 href="https://doi.org/10.1002/cncr.22735">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d19341e1151 class=n-a></a>Callery MP, Chang KJ, Fishman EK, <i> et al.</i>: Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. <i>Ann Surg Oncol.</i> 2009; <b>16</b>(7): 172733. <a target=xrefwindow id=d19341e1162 href="http://www.ncbi.nlm.nih.gov/pubmed/19396496">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1165 href="https://doi.org/10.1245/s10434-009-0408-6">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d19341e1174 class=n-a></a>Varadhachary GR, Tamm EP, Abbruzzese JL, <i> et al.</i>: Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. <i>Ann Surg Oncol.</i> 2006; <b>13</b>(8): 103546. <a target=xrefwindow id=d19341e1185 href="http://www.ncbi.nlm.nih.gov/pubmed/16865597">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1188 href="https://doi.org/10.1245/ASO.2006.08.011">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d19341e1198 class=n-a></a>Willett CG, Lewandrowski K, Warshaw AL, <i> et al.</i>: Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. <i>Ann Surg.</i> 1993; <b>217</b>(2): 1448. <a target=xrefwindow id=d19341e1209 href="http://www.ncbi.nlm.nih.gov/pubmed/8094952">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1212 href="https://doi.org/10.1097/00000658-199302000-00008">Publisher Full Text </a> | <a target=xrefwindow id=d19341e1216 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1242753">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d19341e1225 class=n-a></a>Yeo CJ, Cameron JL, Lillemoe KD, <i> et al.</i>: Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. <i>Ann Surg.</i> 1995; <b>221</b>(6): 72131; discussion 7313. <a target=xrefwindow id=d19341e1236 href="http://www.ncbi.nlm.nih.gov/pubmed/7794076">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1239 href="https://doi.org/10.1097/00000658-199506000-00011">Publisher Full Text </a> | <a target=xrefwindow id=d19341e1243 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1234702">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d19341e1252 class=n-a></a>Nitecki SS, Sarr MG, Colby TV, <i> et al.</i>: Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? <i>Ann Surg.</i> 1995; <b>221</b>(1): 5966. <a target=xrefwindow id=d19341e1263 href="http://www.ncbi.nlm.nih.gov/pubmed/7826162">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1266 href="https://doi.org/10.1097/00000658-199501000-00007">Publisher Full Text </a> | <a target=xrefwindow id=d19341e1270 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1234495">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d19341e1279 class=n-a></a>Sohn TA, Yeo CJ, Cameron JL, <i> et al.</i>: Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. <i>J Gastrointest Surg.</i> 2000; <b>4</b>(6): 56779. <a target=xrefwindow id=d19341e1290 href="http://www.ncbi.nlm.nih.gov/pubmed/11307091">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1293 href="https://doi.org/10.1016/S1091-255X(00)80105-5">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d19341e1302 class=n-a></a>Neoptolemos JP, Stocken DD, Dunn JA, <i> et al.</i>: Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. <i>Ann Surg.</i> 2001; <b>234</b>(6): 75868. <a target=xrefwindow id=d19341e1313 href="http://www.ncbi.nlm.nih.gov/pubmed/11729382">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1316 href="https://doi.org/10.1097/00000658-200112000-00007">Publisher Full Text </a> | <a target=xrefwindow id=d19341e1320 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1422135">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d19341e1329 class=n-a></a>Nishimura Y, Hosotani R, Shibamoto Y, <i> et al.</i>: External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer: analysis of survival rates and complications. <i>Int J Radiat Oncol Biol Phys.</i> 1997; <b>39</b>(1): 3949. <a target=xrefwindow id=d19341e1340 href="http://www.ncbi.nlm.nih.gov/pubmed/9300738">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1343 href="https://doi.org/10.1016/S0360-3016(97)00295-2">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d19341e1353 class=n-a></a>Millikan KW, Deziel DJ, Silverstein JC, <i> et al.</i>: Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas. <i>Am Surg.</i> 1999; <b>65</b>(7): 61823; discussion 6234. <a target=xrefwindow id=d19341e1364 href="http://www.ncbi.nlm.nih.gov/pubmed/10399969">PubMed Abstract </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d19341e1373 class=n-a></a>Benassai G, Mastrorilli M, Quarto G, <i> et al.</i>: Survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. <i>Chir Ital.</i> 2000; <b>52</b>(3): 26370. <a target=xrefwindow id=d19341e1384 href="http://www.ncbi.nlm.nih.gov/pubmed/10932371">PubMed Abstract </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d19341e1393 class=n-a></a>Kuhlmann KF, de Castro SM, Wesseling JG, <i> et al.</i>: Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. <i>Eur J Cancer.</i> 2004; <b>40</b>(4): 54958. <a target=xrefwindow id=d19341e1404 href="http://www.ncbi.nlm.nih.gov/pubmed/14962722">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1407 href="https://doi.org/10.1016/j.ejca.2003.10.026">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d19341e1416 class=n-a></a>Gall FP, Kessler H, Hermanek P: Surgical treatment of ductal pancreatic carcinoma. <i>Eur J Surg Oncol.</i> 1991; <b>17</b>(2): 17381. <a target=xrefwindow id=d19341e1424 href="http://www.ncbi.nlm.nih.gov/pubmed/2015922">PubMed Abstract </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d19341e1433 class=n-a></a>Trede M, Schwall G, Saeger HD: Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. <i>Ann Surg.</i> 1990; <b>211</b>(4): 44758. <a target=xrefwindow id=d19341e1441 href="http://www.ncbi.nlm.nih.gov/pubmed/2322039">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1444 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1358031">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d19341e1453 class=n-a></a>Richter A, Niedergethmann M, Sturm JW, <i> et al.</i>: Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. <i>World J Surg.</i> 2003; <b>27</b>(3): 3249. <a target=xrefwindow id=d19341e1464 href="http://www.ncbi.nlm.nih.gov/pubmed/12607060">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1467 href="https://doi.org/10.1007/s00268-002-6659-z">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d19341e1477 class=n-a></a>Takai S, Satoi S, Toyokawa H, <i> et al.</i>: Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: A retrospective, single-institution experience. <i>Pancreas.</i> 2003; <b>26</b>(3): 2439. <a target=xrefwindow id=d19341e1488 href="http://www.ncbi.nlm.nih.gov/pubmed/12657950">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1491 href="https://doi.org/10.1097/00006676-200304000-00007">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d19341e1500 class=n-a></a>Li D, Xie K, Wolff R, <i> et al.</i>: Pancreatic cancer. <i>Lancet.</i> 2004; <b>363</b>: 104957. <a target=xrefwindow id=d19341e1511 href="http://www.ncbi.nlm.nih.gov/pubmed/15051286">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1514 href="https://doi.org/10.1016/S0140-6736(04)15841-8">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d19341e1523 class=n-a></a>Sauer R, Liersch T, Merkel S, <i> et al.</i>: Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. <i>J Clin Oncol.</i> 2012; <b>30</b>(16): 192633. <a target=xrefwindow id=d19341e1534 href="http://www.ncbi.nlm.nih.gov/pubmed/22529255">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1537 href="https://doi.org/10.1200/JCO.2011.40.1836">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717147902"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d19341e1546 class=n-a></a>van Hagen P, Hulshof MC, Van Lanschot JJ, <i> et al.</i>: Preoperative chemoradiotherapy for esophageal or junctional cancer. <i>N Engl J Med.</i> 2012; <b>366</b>(22): 207484. <a target=xrefwindow id=d19341e1557 href="http://www.ncbi.nlm.nih.gov/pubmed/22646630">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1560 href="https://doi.org/10.1056/NEJMoa1112088">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717147902">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d19341e1573 class=n-a></a>Raut CP, Tseng JF, Sun CC, <i> et al.</i>: Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. <i>Ann Surg.</i> 2007; <b>246</b>(1): 5260. <a target=xrefwindow id=d19341e1584 href="http://www.ncbi.nlm.nih.gov/pubmed/17592291">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1587 href="https://doi.org/10.1097/01.sla.0000259391.84304.2b">Publisher Full Text </a> | <a target=xrefwindow id=d19341e1591 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1899216">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d19341e1600 class=n-a></a>Ishikawa O, Ohhigashi H, Teshima T, <i> et al.</i>: Clinical and histopathological appraisal of preoperative irradiation for adenocarcinoma of the pancreatoduodenal region. <i>J Surg Oncol.</i> 1989; <b>40</b>(3): 14351. <a target=xrefwindow id=d19341e1611 href="http://www.ncbi.nlm.nih.gov/pubmed/2918720">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1614 href="https://doi.org/10.1002/jso.2930400303">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d19341e1624 class=n-a></a>Lowy AM, Lee JE, Pisters PW, <i> et al.</i>: Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. <i>Ann Surg.</i> 1997; <b>226</b>(5): 63241. <a target=xrefwindow id=d19341e1635 href="http://www.ncbi.nlm.nih.gov/pubmed/9389397">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1638 href="https://doi.org/10.1097/00000658-199711000-00008">Publisher Full Text </a> | <a target=xrefwindow id=d19341e1642 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1191125">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d19341e1651 class=n-a></a>Cheng TY, Sheth K, White RR, <i> et al.</i>: Effect of neoadjuvant chemoradiation on operative mortality and morbidity for pancreaticoduodenectomy. <i>Ann Surg Oncol.</i> 2006; <b>13</b>(1): 6674. <a target=xrefwindow id=d19341e1662 href="http://www.ncbi.nlm.nih.gov/pubmed/16372154">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1665 href="https://doi.org/10.1245/ASO.2006.02.003">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727254012"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d19341e1674 class=n-a></a>Russo S, Saif MW: Neoadjuvant therapy for pancreatic cancer: an ongoing debate. <i>Therap Adv Gastroenterol.</i> 2016; <b>9</b>(4): 42936. <a target=xrefwindow id=d19341e1682 href="http://www.ncbi.nlm.nih.gov/pubmed/27366211">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1685 href="https://doi.org/10.1177/1756283X16646524">Publisher Full Text </a> | <a target=xrefwindow id=d19341e1688 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4913343">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727254012">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d19341e1701 class=n-a></a>Gillen S, Schuster T, Meyer Zum Bschenfelde C, <i> et al.</i>: Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. <i>PLoS Med.</i> 2010; <b>7</b>(4): e1000267. <a target=xrefwindow id=d19341e1712 href="http://www.ncbi.nlm.nih.gov/pubmed/20422030">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1715 href="https://doi.org/10.1371/journal.pmed.1000267">Publisher Full Text </a> | <a target=xrefwindow id=d19341e1719 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2857873">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725423460"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d19341e1728 class=n-a></a>Golcher H, Brunner TB, Witzigmann H, <i> et al.</i>: Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized phase II trial. <i>Strahlenther Onkol.</i> 2015; <b>191</b>(1): 716. <a target=xrefwindow id=d19341e1739 href="http://www.ncbi.nlm.nih.gov/pubmed/25252602">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1742 href="https://doi.org/10.1007/s00066-014-0737-7">Publisher Full Text </a> | <a target=xrefwindow id=d19341e1746 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4289008">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725423460">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d19341e1759 class=n-a></a>van Tienhoven G, Versteijne E, Suker M, <i> et al.</i>: Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC-1): A randomized, controlled, multicenter phase III trial. <i>J Clin Oncol.</i> 2018; <b>36</b>(18_suppl): LBA4002. <a target=xrefwindow id=d19341e1770 href="https://doi.org/10.1200/JCO.2018.36.18_suppl.LBA4002">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d19341e1780 class=n-a></a>Katz MHG, Ou FS, Herman JM, <i> et al.</i>: Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas. <i>BMC Cancer.</i> 2017; <b>17</b>(1): 505. <a target=xrefwindow id=d19341e1791 href="http://www.ncbi.nlm.nih.gov/pubmed/28750659">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1794 href="https://doi.org/10.1186/s12885-017-3441-z">Publisher Full Text </a> | <a target=xrefwindow id=d19341e1798 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5530569">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726327760"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d19341e1807 class=n-a></a>Hammel P, Huguet F, van Laethem JL, <i> et al.</i>: Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial. <i>JAMA.</i> 2016; <b>315</b>(17): 184453. <a target=xrefwindow id=d19341e1818 href="http://www.ncbi.nlm.nih.gov/pubmed/27139057">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1821 href="https://doi.org/10.1001/jama.2016.4324">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726327760">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d19341e1834 class=n-a></a>Chauffert B, Mornex F, Bonnetain F, <i> et al.</i>: Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study. <i>Ann Oncol.</i> 2008; <b>19</b>(9): 15929. <a target=xrefwindow id=d19341e1845 href="http://www.ncbi.nlm.nih.gov/pubmed/18467316">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1848 href="https://doi.org/10.1093/annonc/mdn281">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727579091"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d19341e1857 class=n-a></a>Chung SY, Chang JS, Lee BM, <i> et al.</i>: Dose escalation in locally advanced pancreatic cancer patients receiving chemoradiotherapy. <i>Radiother Oncol.</i> 2017; <b>123</b>(3): 43845. <a target=xrefwindow id=d19341e1868 href="http://www.ncbi.nlm.nih.gov/pubmed/28464997">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1871 href="https://doi.org/10.1016/j.radonc.2017.04.010">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727579091">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d19341e1884 class=n-a></a>Krishnan S, Chadha AS, Suh Y, <i> et al.</i>: Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation. <i>Int J Radiat Oncol Biol Phys.</i> 2016; <b>94</b>(4): 75565. <a target=xrefwindow id=d19341e1895 href="http://www.ncbi.nlm.nih.gov/pubmed/26972648">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1898 href="https://doi.org/10.1016/j.ijrobp.2015.12.003">Publisher Full Text </a> | <a target=xrefwindow id=d19341e1902 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4792191">Free Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725291201"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d19341e1911 class=n-a></a>Herman JM, Chang DT, Goodman KA, <i> et al.</i>: Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma. <i>Cancer.</i> 2015; <b>121</b>(7): 112837. <a target=xrefwindow id=d19341e1922 href="http://www.ncbi.nlm.nih.gov/pubmed/25538019">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1925 href="https://doi.org/10.1002/cncr.29161">Publisher Full Text </a> | <a target=xrefwindow id=d19341e1929 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4368473">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725291201">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d19341e1943 class=n-a></a>Katz MH, Pisters PW, Evans DB, <i> et al.</i>: Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. <i>J Am Coll Surg.</i> 2008; <b>206</b>(5): 83346; discussion 8468. <a target=xrefwindow id=d19341e1954 href="http://www.ncbi.nlm.nih.gov/pubmed/18471707">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1957 href="https://doi.org/10.1016/j.jamcollsurg.2007.12.020">Publisher Full Text </a> | <a target=xrefwindow id=d19341e1961 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5901743">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725318150"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d19341e1970 class=n-a></a>Ferrone CR, Marchegiani G, Hong TS, <i> et al.</i>: Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer. <i>Ann Surg.</i> 2015; <b>261</b>(1): 127. <a target=xrefwindow id=d19341e1981 href="http://www.ncbi.nlm.nih.gov/pubmed/25599322">PubMed Abstract </a> | <a target=xrefwindow id=d19341e1984 href="https://doi.org/10.1097/SLA.0000000000000867">Publisher Full Text </a> | <a target=xrefwindow id=d19341e1988 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4349683">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725318150">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d19341e2001 class=n-a></a>Venkatesulu BP, Mallick S, Lin SH, <i> et al.</i>: A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors. <i>Crit Rev Oncol Hematol.</i> 2018; <b>123</b>: 4251. <a target=xrefwindow id=d19341e2012 href="http://www.ncbi.nlm.nih.gov/pubmed/29482778">PubMed Abstract </a> | <a target=xrefwindow id=d19341e2015 href="https://doi.org/10.1016/j.critrevonc.2018.01.003">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d19341e2024 class=n-a></a>Balmanoukian A, Ye X, Herman J, <i> et al.</i>: The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas. <i>Cancer Invest.</i> 2012; <b>30</b>(8): 5716. <a target=xrefwindow id=d19341e2035 href="http://www.ncbi.nlm.nih.gov/pubmed/22812722">PubMed Abstract </a> | <a target=xrefwindow id=d19341e2038 href="https://doi.org/10.3109/07357907.2012.700987">Publisher Full Text </a> | <a target=xrefwindow id=d19341e2042 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3557506">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d19341e2051 class=n-a></a>Wild AT, Ye X, Ellsworth SG, <i> et al.</i>: The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma. <i>Am J Clin Oncol.</i> 2015; <b>38</b>(3): 25965. <a target=xrefwindow id=d19341e2062 href="http://www.ncbi.nlm.nih.gov/pubmed/23648440">PubMed Abstract </a> | <a target=xrefwindow id=d19341e2065 href="https://doi.org/10.1097/COC.0b013e3182940ff9">Publisher Full Text </a> | <a target=xrefwindow id=d19341e2069 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3991773">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d19341e2078 class=n-a></a>Chadha AS, Liu G, Chen HC, <i> et al.</i>: Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy? <i>Int J Radiat Oncol Biol Phys.</i> 2017; <b>97</b>(2): 32332. <a target=xrefwindow id=d19341e2089 href="http://www.ncbi.nlm.nih.gov/pubmed/28068240">PubMed Abstract </a> | <a target=xrefwindow id=d19341e2092 href="https://doi.org/10.1016/j.ijrobp.2016.10.046">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d19341e2102 class=n-a></a>Dahlin AM, Henriksson ML, Van Guelpen B, <i> et al.</i>: Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor. <i>Mod Pathol.</i> 2011; <b>24</b>(5): 67182. <a target=xrefwindow id=d19341e2113 href="http://www.ncbi.nlm.nih.gov/pubmed/21240258">PubMed Abstract </a> | <a target=xrefwindow id=d19341e2116 href="https://doi.org/10.1038/modpathol.2010.234">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d19341e2125 class=n-a></a>Yasuda K, Nirei T, Sunami E, <i> et al.</i>: Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer. <i>Radiat Oncol.</i> 2011; <b>6</b>: 49. <a target=xrefwindow id=d19341e2136 href="http://www.ncbi.nlm.nih.gov/pubmed/21575175">PubMed Abstract </a> | <a target=xrefwindow id=d19341e2139 href="https://doi.org/10.1186/1748-717X-6-49">Publisher Full Text </a> | <a target=xrefwindow id=d19341e2143 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3120676">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d19341e2152 class=n-a></a>Teixid C, Gonzlez-Cao M, Karachaliou N, <i> et al.</i>: Predictive factors for immunotherapy in melanoma. <i>Ann Transl Med.</i> 2015; <b>3</b>(15): 208. <a target=xrefwindow id=d19341e2163 href="http://www.ncbi.nlm.nih.gov/pubmed/26488004">PubMed Abstract </a> | <a target=xrefwindow id=d19341e2166 href="https://doi.org/10.3978/j.issn.2305-5839.2015.05.07">Publisher Full Text </a> | <a target=xrefwindow id=d19341e2170 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4583591">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d19341e2179 class=n-a></a>Seung SK, Curti BD, Crittenden M, <i> et al.</i>: Phase 1 study of stereotactic body radiotherapy and interleukin-2--tumor and immunological responses. <i>Sci Transl Med.</i> 2012; <b>4</b>(137): 137ra74. <a target=xrefwindow id=d19341e2190 href="http://www.ncbi.nlm.nih.gov/pubmed/22674552">PubMed Abstract </a> | <a target=xrefwindow id=d19341e2193 href="https://doi.org/10.1126/scitranslmed.3003649">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d19341e2202 class=n-a></a>Wild AT, Herman JM, Dholakia AS, <i> et al.</i>: Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic Cancer. <i>Int J Radiat Oncol Biol Phys.</i> 2016; <b>94</b>(3): 5719. <a target=xrefwindow id=d19341e2213 href="http://www.ncbi.nlm.nih.gov/pubmed/26867885">PubMed Abstract </a> | <a target=xrefwindow id=d19341e2216 href="https://doi.org/10.1016/j.ijrobp.2015.11.026">Publisher Full Text </a> | <a target=xrefwindow id=d19341e2220 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4847529">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d19341e2229 class=n-a></a>Faltynek CR, Wang S, Miller D, <i> et al.</i>: Administration of human recombinant IL-7 to normal and irradiated mice increases the numbers of lymphocytes and some immature cells of the myeloid lineage. <i>J Immunol.</i> 1992; <b>149</b>(4): 127682. <a target=xrefwindow id=d19341e2240 href="http://www.ncbi.nlm.nih.gov/pubmed/1500718">PubMed Abstract </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725638469"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d19341e2250 class=n-a></a>Mathios D, Park CK, Marcus WD, <i> et al.</i>: Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model. <i>Int J Cancer.</i> 2016; <b>138</b>(1): 18794. <a target=xrefwindow id=d19341e2261 href="http://www.ncbi.nlm.nih.gov/pubmed/26174883">PubMed Abstract </a> | <a target=xrefwindow id=d19341e2264 href="https://doi.org/10.1002/ijc.29686">Publisher Full Text </a> | <a target=xrefwindow id=d19341e2268 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4696021">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725638469">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734605268"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d19341e2281 class=n-a></a>Pilones K, Aryankalayil J, Formenti S, <i> et al.</i>: Intratumoral IL-15 potentiates radiation-induced anti-tumor immunity. <i>J Immunother Cancer.</i> 2015; <b>3</b>(Suppl 2): P239. <a target=xrefwindow id=d19341e2292 href="https://doi.org/10.1186/2051-1426-3-S2-P239">Publisher Full Text </a> | <a target=xrefwindow id=d19341e2295 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4649461">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734605268">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d19341e2308 class=n-a></a>Clinicaltrials.gov: A Phase I and Pilot Study of the Effect of rhIL-7-hyFc (NT-I7) on CD4 Counts in Patients With High Grade Gliomas and Severe Treatment-related CD4 Lymphopenia After Concurrent Radiation and Temozolomide. ClinicalTrials.gov. [online]. 2018. <a target=xrefwindow id=d19341e2310 href="https://clinicaltrials.gov/ct2/show/NCT02659800?term=interleukin+7+And+radiation&amp;rank=1 L-iILCCACRaTTiPWHGG-FTV-CgIc">Reference Source</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d19341e2319 class=n-a></a>Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma KC, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer. ClinicalTrials.gov [online]. [Accessed April 5 2017]. <a target=xrefwindow id=d19341e2321 href="https://clinicaltrials.gov/ct2/show/NCT01727076?term=Interleukin+15&amp;rank=1">Reference Source</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1157587"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d19341e2330 class=n-a></a>Dudley ME, Yang JC, Sherry R, <i> et al.</i>: Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. <i>J Clin Oncol.</i> 2008; <b>26</b>(32): 52339. <a target=xrefwindow id=d19341e2341 href="http://www.ncbi.nlm.nih.gov/pubmed/18809613">PubMed Abstract </a> | <a target=xrefwindow id=d19341e2344 href="https://doi.org/10.1200/JCO.2008.16.5449">Publisher Full Text </a> | <a target=xrefwindow id=d19341e2348 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2652090">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1157587">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d19341e2361 class=n-a></a>Campian JL, Ye X, Gladstone DE, <i> et al.</i>: Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas. <i>J Neurooncol.</i> 2015; <b>124</b>(2): 30716. <a target=xrefwindow id=d19341e2372 href="http://www.ncbi.nlm.nih.gov/pubmed/26070554">PubMed Abstract </a> | <a target=xrefwindow id=d19341e2375 href="https://doi.org/10.1007/s11060-015-1841-y">Publisher Full Text </a> | <a target=xrefwindow id=d19341e2379 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4696006">Free Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d19341e2389 class=n-a></a>Thind K, Padrnos LJ, Ramanathan RK, <i> et al.</i>: Immunotherapy in pancreatic cancer treatment: a new frontier. <i>Therap Adv Gastroenterol.</i> 2017; <b>10</b>(1): 16894. <a target=xrefwindow id=d19341e2400 href="http://www.ncbi.nlm.nih.gov/pubmed/28286568">PubMed Abstract </a> | <a target=xrefwindow id=d19341e2403 href="https://doi.org/10.1177/1756283X16667909">Publisher Full Text </a> | <a target=xrefwindow id=d19341e2407 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5330603">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d19341e2416 class=n-a></a>Reynders K, De Ruysscher D: Radiotherapy and Immunotherapy: Improving Cancer Treatment through Synergy. <i>Prog Tumor Res.</i> 2015; <b>42</b>: 6778. <a target=xrefwindow id=d19341e2424 href="http://www.ncbi.nlm.nih.gov/pubmed/26383848">PubMed Abstract </a> | <a target=xrefwindow id=d19341e2427 href="https://doi.org/10.1159/000437185">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d19341e2436 class=n-a></a>Vatner RE, Cooper BT, Vanpouille-Box C, <i> et al.</i>: Combinations of immunotherapy and radiation in cancer therapy. <i>Front Oncol.</i> 2014; <b>4</b>: 325. <a target=xrefwindow id=d19341e2447 href="http://www.ncbi.nlm.nih.gov/pubmed/25506582">PubMed Abstract </a> | <a target=xrefwindow id=d19341e2450 href="https://doi.org/10.3389/fonc.2014.00325">Publisher Full Text </a> | <a target=xrefwindow id=d19341e2454 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4246656">Free Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d19341e2463 class=n-a></a>Vanpouille-Box C, Diamond JM, Pilones KA, <i> et al.</i>: TGF Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity. <i>Cancer Res.</i> 2015; <b>75</b>(11): 223242. <a target=xrefwindow id=d19341e2474 href="http://www.ncbi.nlm.nih.gov/pubmed/25858148">PubMed Abstract </a> | <a target=xrefwindow id=d19341e2477 href="https://doi.org/10.1158/0008-5472.CAN-14-3511">Publisher Full Text </a> | <a target=xrefwindow id=d19341e2481 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4522159">Free Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d19341e2490 class=n-a></a>Kuo P, Bratman SV, Shultz DB, <i> et al.</i>: Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response. <i>Clin Cancer Res.</i> 2014; <b>20</b>(21): 555869. <a target=xrefwindow id=d19341e2501 href="http://www.ncbi.nlm.nih.gov/pubmed/25189484">PubMed Abstract </a> | <a target=xrefwindow id=d19341e2504 href="https://doi.org/10.1158/1078-0432.CCR-14-1138">Publisher Full Text </a> | <a target=xrefwindow id=d19341e2508 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4216761">Free Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d19341e2517 class=n-a></a>Bernstein MB, Krishnan S, Hodge JW, <i> et al.</i>: Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach? <i>Nat Rev Clin Oncol.</i> 2016; <b>13</b>(8): 51624. <a target=xrefwindow id=d19341e2528 href="http://www.ncbi.nlm.nih.gov/pubmed/26951040">PubMed Abstract </a> | <a target=xrefwindow id=d19341e2531 href="https://doi.org/10.1038/nrclinonc.2016.30">Publisher Full Text </a> | <a target=xrefwindow id=d19341e2535 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6053911">Free Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d19341e2545 class=n-a></a>Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer. ClinicalTrials.gov. <a target=xrefwindow id=d19341e2547 href="https://clinicaltrials.gov/ct2/show/NCT02405585">Reference Source</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d19341e2556 class=n-a></a>Pancreatic Tumor Cell Vaccine (GVAX), Low Dose Cyclophosphamide, Fractionated Stereotactic Body Radiation Therapy (SBRT), and FOLFIRINOX Chemotherapy in Patients With Resected Adenocarcinoma of the Pancreas. ClinicalTrials.gov. <a target=xrefwindow id=d19341e2558 href="https://clinicaltrials.gov/ct2/show/NCT01595321">Reference Source</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d19341e2567 class=n-a></a>Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer. ClinicalTrials.gov. <a target=xrefwindow id=d19341e2569 href="https://clinicaltrials.gov/ct2/show/NCT03563248">Reference Source</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d19341e2578 class=n-a></a>Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer. ClinicalTrials.gov. <a target=xrefwindow id=d19341e2580 href="https://clinicaltrials.gov/ct2/show/NCT03104439">Reference Source</a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d19341e2589 class=n-a></a>Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer. ClinicalTrials.gov. <a target=xrefwindow id=d19341e2591 href="https://clinicaltrials.gov/ct2/show/NCT02305186">Reference Source</a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d19341e2600 class=n-a></a>Study With CY, Pembrolizumab, GVAX, and SBRT in Patients With Locally Advanced Pancreatic Cancer. ClinicalTrials.gov. <a target=xrefwindow id=d19341e2602 href="https://clinicaltrials.gov/ct2/show/NCT02648282">Reference Source</a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d19341e2612 class=n-a></a>Aliru ML, Schoenhals JE, Venkatesulu BP, <i> et al.</i>: Radiation therapy and immunotherapy: what is the optimal timing or sequencing? <i>Immunotherapy.</i> 2018; <b>10</b>(4): 299316. <a target=xrefwindow id=d19341e2623 href="http://www.ncbi.nlm.nih.gov/pubmed/29421979">PubMed Abstract </a> | <a target=xrefwindow id=d19341e2626 href="https://doi.org/10.2217/imt-2017-0082">Publisher Full Text </a> | <a target=xrefwindow id=d19341e2630 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5810851">Free Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d19341e2639 class=n-a></a>Whatcott CJ, Diep CH, Jiang P, <i> et al.</i>: Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer. <i>Clin Cancer Res.</i> 2015; <b>21</b>(15): 35618. <a target=xrefwindow id=d19341e2650 href="http://www.ncbi.nlm.nih.gov/pubmed/25695692">PubMed Abstract </a> | <a target=xrefwindow id=d19341e2653 href="https://doi.org/10.1158/1078-0432.CCR-14-1051">Publisher Full Text </a> | <a target=xrefwindow id=d19341e2657 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4526394">Free Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 13 Dec 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1931&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1931&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA<br/> <sup>2</sup> Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA<br/> <sup>3</sup> The University of Texas MD Anderson Cancer Center-UT Health Graduate School of Biomedical Sciences, Houston, TX, USA<br/> <sup>4</sup> Department of Radiation Oncology, Chang Gung Memorial Hospital, Linkou and Chang Gung University, Taoyuan, Taiwan<br/> <p> <div class=margin-bottom> Bhanu Prasad Venkatesulu <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Cheng-En Hsieh <br/> <span>Roles: </span> Investigation, Methodology, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Keith L Sanders <br/> <span>Roles: </span> Investigation, Methodology, Writing  Review & Editing </div> <div class=margin-bottom> Sunil Krishnan <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Supervision, Writing  Original Draft Preparation, Writing  Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-1931/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 13 Dec 2018, 7:1931 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.16272.1">https://doi.org/10.12688/f1000research.16272.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2018 Venkatesulu BP <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=17772 data-id=16272 data-downloads="" data-views="" data-scholar="10.12688/f1000research.16272.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-1931/v1/pdf?article_uuid=c14c0f99-905c-4b3b-93f4-9432f9f5896f" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.16272.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Venkatesulu BP, Hsieh CE, Sanders KL and Krishnan S. Recent advances in radiation therapy of pancreatic cancer [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1931 (<a href="https://doi.org/10.12688/f1000research.16272.1" target=_blank>https://doi.org/10.12688/f1000research.16272.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=16272 id=mobile-track-article-signin-16272 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/16272?target=/articles/7-1931"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=17772 /> <input name=articleId type=hidden value=16272 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Terence Sio</strong>, Department of Radiation Oncology, Mayo Clinic, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Jeffrey Meyer</strong>, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 13 Dec 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1931&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1931&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=43003-41753></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=43002-41754></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-1931/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>13 Dec 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Terence Sio</strong>, Department of Radiation Oncology, Mayo Clinic, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Jeffrey Meyer</strong>, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-1931&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-1931/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in radiation therapy of pancreatic...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-1931/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-1931/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-1931/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Venkatesulu BP et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-1931/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-1931",
            templates : {
                twitter : "Recent advances in radiation therapy of pancreatic cancer. Venkatesulu BP et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-1931/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in radiation therapy of pancreatic cancer", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in radiation therapy of pancreatic cancer", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/16272/17772")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "17772");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "41752": 0,
                           "41753": 0,
                           "41754": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "cbbc0e3b-d5ae-4481-8589-ef1bde70e1b0";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1931.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1931.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1931.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-1931.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-1931.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>